Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NW-G01

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
NW-G01, produced by Streptomyces alboflavus 313, is a novel cyclic hexapeptide antibiotic with many potential applications… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2011
2011
NW-G01, a cyclic hexapeptide antibiotic, and 34-epi-NW-G01 were synthesized by the highly stereoselective convergent approach for… Expand
  • figure 1
Is this relevant?
2011
2011
NW-G03, a related cyclic hexapeptide compound of NW-G01, produced by Streptomyces alboflavus 313 
  • table 1
  • table 2
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2010
2010
Correction to: The Journal of Antibiotics (2010) 63, 231–235; doi:10.1038/ja.2010.24 The authors of the above article noted some… Expand
  • figure 1
Is this relevant?
2010
2010
  • Z. Guo, Z. Ji, +4 authors W. Wu
  • The Journal of Antibiotics
  • 2010
  • Corpus ID: 28764176
NW-G01 is a novel cyclic hexapeptide antibiotic produced by Streptomyces alboflavus 313. Its relative structure was established… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2009
2009
NW-G01, a novel cyclic hexadepsipeptide antibiotic, was isolated by macroporous resin and silica gel column chromatography and… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?